Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Curasan AG       DE0005494538

CURASAN AG

SummaryNewsRatingsCalendarCompany 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news
All news about CURASAN AG
07/29CURASAN AG : Preliminary announcement of the publication of financial reports ac..
EQ
06/30CURASAN AG : curasan AG postpones annual financial report 2019 to 31 July 2020
EQ
06/29CURASAN AG : Preliminary announcement of the publication of financial reports ac..
EQ
06/25CURASAN AG : curasan AG and Donau Invest, Vienna, agree on a restructuring conce..
EQ
06/17CURASAN AG : Notification of a loss amounting to half of the equity capital in a..
EQ
06/08CURASAN AG : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
06/03CURASAN AG : Opening of insolvency proceedings on the assets of curasan AG
EQ
05/25CURASAN AG : EBITDA 2019 probably better than results forecast
EQ
04/28CURASAN AG : Preliminary announcement of the publication of financial reports ac..
EQ
04/15CURASAN : postpones publication of FY results 2019
PU
04/15CURASAN : postpones publication of FY results 2019
EQ
03/16CURASAN : New CEO at curasan AG
PU
03/16CURASAN : New CEO at curasan AG
EQ
03/05CURASAN AG : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
02/28CURASAN AG : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
02/23CURASAN AG : Filing of application for insolvency proceedings
EQ
2019CURASAN : stabilizes portfolio business in the third quarter and intensifies par..
PU
2019CURASAN : stabilizes portfolio business in the third quarter and intensifies par..
EQ
2019CURASAN AG : Release according to Article 41 of the WpHG [the German Securities ..
EQ
2019CURASAN AG : REVERSE SPLIT: 1 of 3
FA
2019CURASAN AG : Annual General Meeting 2019
EQ
2019CURASAN : increases sales considerably in the first quarter
PU
2019CURASAN : must cope with significant setbacks in international sales in 2018
EQ
2019CURASAN AG : Preliminary announcement of the publication of financial reports ac..
EQ
2019CURASAN AG : Volume of convertible bond, further finance commitment by investor,..
EQ
2019CURASAN : postpones publication of annual financial reports 2018
PU
2019CURASAN : decides to issue convertible bond
PU
2019CURASAN AG : Correction of a release from 24/01/2019 according to Article 40, Se..
EQ
2019CURASAN AG : Correction of a release from 22/10/2018 according to Article 40, Se..
EQ
2019CURASAN AG : Extraordinary General Meeting
EQ
2019CURASAN AG : Market clearance for Osbone in Japan
EQ
2019CURASAN AG : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
2018CURASAN AG : Notification and public disclosure of transactions by persons
EQ
2018CURASAN AG : Convening of a General Meeting to report a loss amounting to half o..
PU
2018CURASAN : battles economy political headwinds despite strong domestic demand
EQ
2018CURASAN : battles economy political headwinds despite strong domestic demand
PU
2018CURASAN AG : quaterly earnings release
2018CURASAN : lowers guidance for 2018
PU
2018CURASAN : receives US approval for Ceracell® Ortho Foam
PU
2018CURASAN AG : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
2018CURASAN AG : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
2018CURASAN AG : Release according to Article 41 of the WpHG [the German Securities ..
EQ
2018CURASAN : returns to growth with a 16 percent increase in sales compared to prev..
PU
2018CURASAN : returns to growth with a 16 percent increase in sales compared to prev..
EQ
2018CURASAN AG : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
2018CURASAN AG : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
2018CURASAN AG : Release according to Article 41 of the WpHG [the German Securities ..
EQ
2018CURASAN : grants Private Label-Rights for Hyaluronic Acid used in Osteoarthritis..
PU
2018CURASAN : grants Private Label-Rights for Hyaluronic Acid used in Osteoarthritis..
EQ
2018CURASAN : signs exclusive Cooperation for Hemostatic Product stypro® in Germany
PU
2018CURASAN : signs exclusive Cooperation for Hemostatic Product stypro(R) in German..
EQ
2018CURASAN : concludes first quarter in line with annual guidance
PU
2018CURASAN AG : quaterly earnings release
2018CURASAN : emerges strengthened from 2017
PU
2018CURASAN : emerges strengthened from 2017
EQ
2018CURASAN : implements focused measures
EQ
2018CURASAN AG : Preliminary announcement of the publication of financial reports ac..
EQ
2017CURASAN AG : Release according to Article 26, Section 1 of the WpHG [the German ..
EQ
2017CURASAN : signs new cooperation with Implantcast for the DACH-region
EQ
2017CURASAN AG : Release according to Article 26, Section 1 of the WpHG [the German ..
EQ
2017CURASAN AG : Release according to Article 26, Section 1 of the WpHG [the German ..
EQ
2017CURASAN AG : Release according to Article 26, Section 1 of the WpHG [the German ..
EQ
2017CURASAN AG : Release according to Article 26a of the WpHG [the German Securities..
EQ
2017CURASAN : fully implements also second tranche of capital increase with subscrip..
PU
2017CURASAN : fully implements also second tranche of capital increase with subscrip..
EQ
2017CURASAN : Export sales of curasan continue to rise
PU
2017CURASAN : Export sales of curasan continue to rise
EQ
2017CURASAN : announces Orthopedic Private Label Distribution Agreement
PU
2017CURASAN : announces Orthopedic Private Label Distribution Agreement
EQ
2017CURASAN : Revenue shifts have lowering impact on revenues and earnings
PU
2017CURASAN AG : Release according to Article 26, Section 1 of the WpHG [the German ..
EQ
2017CURASAN AG : Release according to Article 26a of the WpHG [the German Securities..
EQ
2017CURASAN : decides to increase capital in two tranches
PU
2017CURASAN : decides to increase capital in two tranches
EQ
2017CURASAN AG : RIGHTS ISSUE: 8 new shares @ 1.2 EUR for 22 existing shares
FA
1  2Next
Upcoming event on CURASAN AG